Morphine enhances purine nucleotide catabolism in vivo and in vitro

Acta Pharmacologica Sinica

Volumn 28, Issue 8, 2007, Pages 1105-1115

  Liu, Chang ^a   Liu, Jian Kai ^a   Kan, Mu Jie ^a   Gao, Lin ^a   Fu, Hai Ying ^a   Zhou, Hang ^a   Hong, Min ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Adenosine deaminase; Morphine; Purine nucleotide; Uric acid; Xanthine oxidase

Indexed keywords

ADENOSINE DEAMINASE; CREATININE; MORPHINE; NALOXONE; PURINE NUCLEOTIDE; URATE OXIDASE; URIC ACID; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG WITHDRAWAL; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME DEGRADATION; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLIOMA CELL; LIVER; MORPHINE ADDICTION; NONHUMAN; PARIETAL LOBE; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; SMALL INTESTINE; SOUTHERN BLOTTING; STATISTICAL SIGNIFICANCE; UPREGULATION; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADENOSINE DEAMINASE; ANIMALS; BLOOD UREA NITROGEN; CELL LINE, TUMOR; FEMALE; MORPHINE; PURINE NUCLEOTIDES; RATS; RATS, WISTAR; RNA, MESSENGER; URIC ACID; XANTHINE OXIDASE;

EID: 34547574033     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00592.x     Document Type: Article

References (33)

1. Ling GSF, Spiegel K, Nishimura S, Pasternak GW. Dissociation of morphine's analgesic and respiratory depressant actions. Eur J Pharm 1983 149 : 403 40.
2. Jaffe JM, Martin WR. Opioid analgesics and antagonists. In : Gilman A, Rall J, Nies M, Taylor P, editors. The pharmacologic basis of therapeutics 8th ed. New York : Pergamon Press 1990. p 485 573.
3. Jones KL, Barr GA. Ontogeny of morphine withdrawal in the rat. Behav Neurosci 1995 109 : 1189 98.
4. Bilsky EJ, Bernstein RN, Wang Z, Sadée W, Porreca F. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice. J Pharm Exp Ther 1996 277 : 484 90.
5. Yang YD, Zhang JZ, Sun C, Yu HM, Li Q, Hong M. Heroin affects purine nucleotides catabolism in rats in vivo. Life Sci 2006 13 : 1413 8.
6. Liu JK, Hong M, Zhao XD. Effect of morphine on gene expression of gene of enzymes related to purine nucleotide metabolism in c6 glioma. Natl Med J China 2003 83 : 46 51.
7. Stiene-Martin A, Hauser KF. Morphine suppresses DNA synthesis in cultured murine astrocytes from cortex, hippocampus and striatum. Neurosci Lett 1993 157 : 1 3.
8. Hauser KF. Morphine regulates DNA synthesis in rat cerebellar neuroblasts in vitro. Brain Res Dev Brain Res 1992 70 : 291 7.
9. Nassiri MR, Flynn GL, Shipman C Jr. Inhibition of cell growth and DNA, RNA, and protein synthesis in vitro by fentanyl, sufentanil, and opiate analgesics. Pharmacol Toxicol 1991 69 : 17 21.
10. Jacobs EH, Smit AB, de Vries TJ, Schoffelmeer AN. Long-term gene expression in the nucleus accumbens following heroin administration is subregion-specific and depends on the nature of drug administration. Addict Biol 2005 10 : 91 100.
11. Kahn L, Alonso G, Normand E, Manzoni OJ. Repeated morphine treatment alters polysialylated neural cell adhesion molecule, glutamate decarboxylase-67 expression and cell proliferation in the adult rat hippocampus. Eur J Neurosci 2005 21 : 493 500.
12. Coupar IM, Tran BL. Withdrawal and bidirectional cross-withdrawal responses in rats treated with adenosine agonists and morphine. Life Sci 2001 69 : 779 90.
13. Sawynok J, Liu XJ. Adenosine in the spinal cord and periphery: release and regulation of pain. Prog Neurobiol 2003 69 : 313 40.
14. Agteresch HJ, Dagnelie PC, van den Berg JW, Wilson JH. Adenosine triphosphate: established and potential clinical applications. Drugs 1999 58 : 211 32.
15. Golembiowska K, White TD, Sawynok J. Modulation of adenosine release from rat spinal cord by adenosine deaminase and adenosine kinase inhibitors. Brain Res 1995 699 : 315 20.
16. Bie B, Peng Y, Zhang Y, Pan ZZ. cAMP-mediated mechanisms for pain sensitization during opioid withdrawal. J Neurosci 2005 25 : 3824 32.
17. Liang DY, Clark JD. Modulation of the NO/CO-cGMP signaling cascade during chronic morphine exposure in mice. Neurosci Lett 2004 15 : 73 7.
18. Serova LI, Maharjan S, Huang A, Sun D, Kaley G, Sabban EL. Response of tyrosine hydroxylase and GTP cyclohydrolase I gene expression to estrogen in brain catecholaminergic regions varies with mode of administration. Brain Res 2004 1015 : 1 8.
19. Zocchi A, Girlanda E, Varnier G, Sartori I, Zanetti L, Wildish GA. Dopamine responsiveness to drugs of abuse: A shell-core investigation in the nucleus accumbens of the mouse. Synapse 2003 50 : 293 302.
20. Tassin JP. Role of dopamine in drug dependence processes. Bull Acad Natl Med 2002 186 : 295 305.
21. Pryor SC, Zhu W, Cadet P, Bianchi E, Guarna M, Stefano GB. Endogenous morphine: opening new doors for the treatment of pain and addiction. Expert Opin Biol Ther 2005 5 : 893 906.
22. Rezayof A, Amini R, Rassouli Y, Zarrindast MR. Influence of nitric oxide on morphine-induced amnesia and interactions with dopaminergic receptor agents. Physiol Behav 2006 88 : 124 31.
23. Phillis JW, Jiang ZG, Chelack BJ, Wu PH. Morphine enhances adenosine release from the in vivo rat cerebral cortex. Eur J Pharmacol 1980 65 : 97 100.
24. Enrico P, Esposito G, Mura MA, Migheli R, Serra PA, Desole MS, et al. Effects of allopurinol on striatal dopamine, ascorbate and uric acid during an acute morphine challenge: ex vivo and in vivo studies. Pharmacol Res 1997 35 : 577 85.
25. Enrico P, Esposito G, Mura MA, Fresu L, De Natale G, Miele E, et al. Effect of morphine on striatal dopamine metabolism and ascorbic and uric acid release in freely moving rats. Brain Res 1997 745 : 173 82.
26. Enrico P, Mura MA, Esposito G, Serra P, Migheli R, De Natale G, et al. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats. Brain Res 1998 797 : 94 102.
27. Robert K, Daryl K, Peter A, Victor W. Harper's Biochemistry. 25th ed. New York : McGraw-Hill Publishers 2000.
28. Bohn LM, Belcheva MM, Coscia CJ. Evidence for μ-opioid receptor expression in C6 glioma cells. J Neurochem 1998 70 : 1819 25.
29. Emmerson PJ, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F. Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor. J Pharmacol Exp Ther 1996 278 : 1121 7.
30. Loh HH, Tao PL, Smith AP. Role of receptor regulation in opioid tolerance mechanisms. Synapse 1988 2 : 245 6.
31. Contet C, Kieffer BL, Befort K. Mu opioid receptor: a gateway to drug addiction. Curr Opin Neurobiol 2004 14 : 370 8.
32. Laurence DR, Bennett PN, Brown MJ. Clinical Pharmacology 8th ed. New York : Harcourt Publishers 1997.
33. Yan XK, Hong M, Liu C, Niu S. Effect of morphine on purine nucleotides metabolism in gene level. Chin J Drug Depend 2005 14 : 187 9.